The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of germline BRCA1/2 mutated (gBRCAmut) hormone receptor-positive (HR+) and triple negative breast cancer (TNBC) treated with talazoparib (TALA).
 
Wolfgang Eiermann
No Relationships to Disclose
 
Hope S. Rugo
Honoraria - Genomic Health
Consulting or Advisory Role - Amgen
Speakers' Bureau - Genomic Health
Research Funding - Eisai (Inst); Genentech (Inst); GTx (Inst); Immunomedics (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Mylan; Novartis; OBI Pharma; Pfizer; Puma Biotechnology; Roche/Genentech
 
Sami Diab
Stock and Other Ownership Interests - Geron; Immunomedics
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - Myriad Genetics; Pfizer
Speakers' Bureau - AstraZeneca; Pfizer
 
Johannes Ettl
Honoraria - Lilly; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Lilly; Novartis; Pfizer
Speakers' Bureau - Celgene; Lilly; Pfizer; Roche; Teva
Travel, Accommodations, Expenses - Celgene; Pfizer; Teva
 
Sara A. Hurvitz
Research Funding - Amgen (Inst); Bayer (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); Dignitana (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Medivation (Inst); Merrimack (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Puma Biotechnology (Inst); sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bayer; Lilly; Novartis; OBI Pharma
 
Anthony Goncalves
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Kyung-Hun Lee
No Relationships to Disclose
 
Louis Fehrenbacher
Research Funding - Roche/Genentech (Inst)
 
Rinat Yerushalmi
No Relationships to Disclose
 
Lida A. Mina
No Relationships to Disclose
 
Miguel Martin
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst); Roche (Inst)
 
Henri Hubert Roche
No Relationships to Disclose
 
Young-Hyuck Im
No Relationships to Disclose
 
Denka Markova
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Iulia Cristina Tudor
Employment - Medivation; Pfizer
Stock and Other Ownership Interests - Medivation; Pfizer
Travel, Accommodations, Expenses - Medivation
 
Joanne Lorraine Blum
Honoraria - Biomarin; Medivation
Consulting or Advisory Role - biomarin; Medivation
Research Funding - Genentech/Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Biomarin; Medivation
 
Alison L. Hannah
Leadership - NeoGenomics Laboratories
Stock and Other Ownership Interests - NeoGenomics Laboratories
Consulting or Advisory Role - Basilea; Jazz Pharmaceuticals; Medivation; Nektar
 
Jennifer Keating Litton
Consulting or Advisory Role - Medivation; Novartis; Pfizer
Speakers' Bureau - Physicans' Education Resource; UpToDate; WebMD
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono; Genentech; GlaxoSmithKline; Jounce Therapeutics; medivation; Novartis; pfizer
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Medivation; pfizer; Physicans' Education Resource